| P50 | author | Kevin Morgan | Q56356187 |
| | Joanna L Richens | Q56440604 |
| | Paul O'Shea | Q56440605 |
| P2093 | author name string | Nin Bajaj | |
| | Fiona Cantlay | |
| | Hannah L Spencer | |
| | Kelly-Ann Vere | |
| | Molly Butler | |
| P2860 | cites work | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway | Q21735927 |
| | Intestinal epithelial cells secrete exosome-like vesicles | Q24291534 |
| | An investigation into the human serum "interactome" | Q24294835 |
| | Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect | Q24295031 |
| | Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin | Q24295284 |
| | A census of human soluble protein complexes | Q24297808 |
| | The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation | Q24299494 |
| | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus | Q24301338 |
| | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways | Q24302034 |
| | Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression | Q24305039 |
| | Proteomic characterization of the human sperm nucleus | Q24305129 |
| | Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6 | Q24314482 |
| | Charting the molecular network of the drug target Bcr-Abl | Q24317707 |
| | An integrated workflow for charting the human interaction proteome: insights into the PP2A system | Q24318802 |
| | Defining the membrane proteome of NK cells | Q24323157 |
| | Network organization of the human autophagy system | Q24324004 |
| | A human protein-protein interaction network: a resource for annotating the proteome | Q24324450 |
| | Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach | Q24337286 |
| | Biosensor-based micro-affinity purification for the proteomic analysis of protein complexes | Q24337793 |
| | The Reactome pathway knowledgebase | Q24567743 |
| | The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease | Q26777969 |
| | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum | Q27322723 |
| | Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways | Q28081678 |
| | Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization | Q28278217 |
| | Reactome: a database of reactions, pathways and biological processes | Q28298042 |
| | Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment | Q28727031 |
| | Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway | Q29870999 |
| | Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease | Q30495250 |
| | Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. | Q31151924 |
| | Assignment of human plasma polypeptides on a nondenaturing 2-D gel using MALDI-MS and PMF and comparisons with the results of intact protein mapping. | Q33271725 |
| | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells | Q33292249 |
| | Proteomic analysis of human blood serum using peptide library beads | Q33299347 |
| | Profiling carbonylated proteins in human plasma | Q33528052 |
| | Data management and functional annotation of the Korean reference plasma proteome | Q33533411 |
| | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability | Q33669652 |
| | The interaction between ubiquitin C-terminal hydrolase 37 and glucose-regulated protein 78 in hepatocellular carcinoma | Q33974989 |
| | Predictome: a database of putative functional links between proteins | Q34010645 |
| | Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid | Q34063961 |
| | Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling | Q34073510 |
| | Mutations in the keratin 9 gene in Pakistani families with epidermolytic palmoplantar keratoderma | Q34154117 |
| | A systems wide mass spectrometric based linear motif screen to identify dominant in-vivo interacting proteins for the ubiquitin ligase MDM2. | Q43540034 |
| | Characterization of differences between blood sample matrices in untargeted metabolomics | Q46925183 |
| | Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia | Q48766140 |
| | Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes | Q50454634 |
| | Reverse engineering of Alzheimer's disease based on biomarker pathways analysis. | Q50620148 |
| | Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease. | Q53345656 |
| | Alzheimer's disease | Q55880664 |
| | Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs) | Q58494051 |
| | Wnt signaling function in Alzheimer's disease | Q74248964 |
| | High-sensitivity analysis of human plasma proteome by immobilized isoelectric focusing fractionation coupled to mass spectrometry identification | Q81012860 |
| | A novel mutation within the 2B rod domain of keratin 9 in a Chinese pedigree with epidermolytic palmoplantar keratoderma combined with knuckle pads and camptodactyly | Q84469991 |
| | [Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma] | Q84585246 |
| | Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients | Q84806086 |
| | Plasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomics | Q34154148 |
| | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5 | Q34154655 |
| | Soluble plasma HLA peptidome as a potential source for cancer biomarkers | Q34279102 |
| | Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). | Q34291582 |
| | Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics | Q34433677 |
| | Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome | Q34556672 |
| | Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms | Q34628212 |
| | The human keratins: biology and pathology | Q34776574 |
| | Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. | Q34910930 |
| | Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease | Q35034130 |
| | A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas | Q35264564 |
| | Mapping the human plasma proteome by SCX-LC-IMS-MS | Q36375781 |
| | Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. | Q36404535 |
| | The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease | Q36660120 |
| | A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry | Q36702842 |
| | Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease | Q36932748 |
| | VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies | Q36953937 |
| | Wnt/beta-catenin signaling controls development of the blood-brain barrier | Q36955697 |
| | The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders. | Q37144218 |
| | Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. | Q37581752 |
| | RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling. | Q37687704 |
| | The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review | Q37692949 |
| | The role of the ubiquitin proteasome system in Alzheimer's disease | Q37850624 |
| | Wnt/β-catenin signaling in Alzheimer's disease. | Q38173457 |
| | Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. | Q38210247 |
| | Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease | Q38214560 |
| | Beyond expectations: novel insights into epidermal keratin function and regulation | Q38222233 |
| | Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer. | Q38342896 |
| | Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome | Q38900580 |
| | Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter | Q38941464 |
| | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability | Q39196735 |
| | Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia | Q39668296 |
| | Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases | Q39860782 |
| | Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid | Q40950201 |
| | Structure and assembly of hemidesmosomes | Q41017393 |
| | Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease | Q42134488 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | biomarker | Q864574 |
| P304 | page(s) | 22962 | |
| P577 | publication date | 2016-03-14 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Rationalising the role of Keratin 9 as a biomarker for Alzheimer's disease | |
| P478 | volume | 6 | |